Understanding Your Starter Dose Options: The Complete Guide
Compare Wegovy and Mounjaro Starter Protocols: Key Differences
When you compare Wegovy and Mounjaro starter approaches, the most significant difference lies in their dose escalation timelines and mechanisms of action. Wegovy begins with a 0.25mg dose administered once weekly for four weeks, designed to allow your body to gradually adapt to semaglutide's appetite-suppressing effects. This gentle introduction helps minimise potential gastrointestinal side effects whilst your system adjusts to the GLP-1 receptor activation. The structured 16-week escalation follows a proven pathway: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), before reaching the 2.4mg maintenance dose.
Mounjaro takes a different approach with tirzepatide, starting at 2.5mg weekly for four weeks before escalating to 5mg, then potentially to 10mg or 15mg based on clinical response. When you compare Wegovy and Mounjaro starter experiences, many patients find Wegovy's lower initial dose more manageable for appetite adjustment. Both treatments require prescription-only medicine status and must be used alongside a reduced-calorie diet and increased physical activity as licensed by the MHRA. Your prescriber will determine which starting approach aligns better with your medical history and weight management goals.
Pricing Structure When You Compare Wegovy and Mounjaro Costs
Understanding the financial commitment helps when you compare Wegovy and Mounjaro options for your starter journey. EverydayMeds supplies Wegovy 0.25mg starter doses at £79.99 with new customer code FIRST40 applied at checkout, whilst returning customers use code DOSE25. Our Intro Duo bundle combines your first two doses (0.25mg and 0.5mg) for £169.99, providing eight weeks of treatment with convenient single delivery. For those preferring a gradual approach, the Gentle Start Trio includes two 0.25mg pens plus one 0.5mg pen for £269.99, allowing extended time at the starter dose if recommended by your prescriber.
When you compare Wegovy and Mounjaro pricing structures, both require ongoing monthly investment throughout your weight management journey. EverydayMeds' transparent pricing eliminates surprise costs, with all fees included in our listed prices. Express prescriber review is available within 24 hours for urgent orders, whilst standard review takes up to three working days. Next-day cold-chain delivery ensures your medication arrives in optimal condition, maintaining the strict temperature requirements essential for both treatments' effectiveness and safety.
Clinical Evidence: How to Compare Wegovy and Mounjaro Trial Data
Clinical trials provide valuable insights when you compare Wegovy and Mounjaro effectiveness, though direct comparisons require careful interpretation due to different study designs and populations. The STEP programme demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1, with similar sustained results in STEP 5's two-year follow-up. The SELECT cardiovascular outcomes trial showed a 20% reduction in major adverse cardiovascular events, highlighting additional health benefits beyond weight management.
Mounjaro's SURMOUNT trials showed different but promising results with tirzepatide's dual mechanism approach targeting both GIP and GLP-1 receptors. When you compare Wegovy and Mounjaro mechanisms, both affect appetite regulation but through different pathways that may suit different patients. Individual responses vary significantly, and trial averages don't predict personal outcomes. Both treatments demonstrated their effectiveness was maintained only whilst continuing medication, emphasising that weight management represents a long-term commitment rather than a short-term solution.
Understanding How Wegovy Works in Your Body
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics glucagon-like peptide-1, a natural hormone your intestines release after eating. This hormone normally signals your brain's appetite centres that you're satisfied and can stop eating, whilst also slowing gastric emptying to maintain fullness for longer periods. By activating these same receptors, Wegovy may help reduce your appetite, increase feelings of satiety after smaller meals, and potentially decrease food cravings between meals. The medication works primarily through your brain's hypothalamic appetite control centres, influencing the complex neural pathways that regulate hunger and satisfaction. Many patients report noticing appetite changes within the first few weeks of starting their 0.25mg dose, though individual responses vary considerably. The gradual dose escalation allows your body to adapt to these neurological changes whilst minimising potential side effects.
Your Complete Ordering Process with EverydayMeds
Starting your weight management journey with EverydayMeds begins with our comprehensive three-minute online clinical assessment, designed to gather essential information about your medical history, current medications, and weight management goals. Our qualified prescribers, working under GPhC registration #9012878, review every assessment to ensure Wegovy suits your individual circumstances and doesn't interact with existing treatments. Standard prescriber review takes up to three working days, whilst our express service provides decisions within 24 hours for urgent requirements. Once approved, your Wegovy starter dose ships via next-day delivery using specialist cold-chain packaging that maintains the crucial 2-8°C temperature throughout transit. Our pharmacy team provides ongoing support throughout your treatment, with clinical guidance available for any questions about dose escalation, side effects, or practical administration concerns.
Storage and Practical Considerations for Long-term Success
Wegovy requires refrigerated storage at 2-8°C before first use, but offers a significant practical advantage over Mounjaro with its ability to remain at room temperature (below 30°C) for up to six weeks once removed from the fridge. This flexibility makes Wegovy particularly suitable for frequent travellers or those with busy lifestyles who might struggle with strict refrigeration requirements. The FlexTouch pen design provides intuitive administration with clear dose markings and an automatic needle cover for safety. Each pen contains four doses, delivered through 32-gauge needles that most patients find comfortable for weekly subcutaneous injection into thigh, upper arm, or abdomen areas. Understanding that dose escalation cannot be skipped helps ensure both safety and optimal effectiveness throughout your 16-week titration period. Proper storage and administration technique significantly impact your treatment success, making these practical considerations crucial when you compare Wegovy and Mounjaro options.
Compare Wegovy and Mounjaro: First-Month Experience Expectations
Your first month experience differs significantly when you compare Wegovy and Mounjaro starter phases, primarily due to their different active ingredients and dose levels. Wegovy's 0.25mg starting dose typically produces gentler initial effects, with many patients experiencing subtle appetite reduction rather than dramatic changes. Some notice decreased interest in large portions or reduced cravings for high-calorie foods, whilst others report feeling satisfied sooner during meals. Potential side effects during this starter phase may include mild nausea, particularly if eating large meals, occasional stomach discomfort, or slight fatigue as your body adjusts.
When you compare Wegovy and Mounjaro first-month tolerability, both treatments emphasise the importance of maintaining your prescribed dose schedule even if effects seem minimal initially. The starter dose serves as preparation for higher therapeutic doses rather than providing maximum weight management effects. Keeping a simple food diary during your first month helps identify which foods trigger any discomfort and allows you to adjust your eating patterns accordingly. Both treatments work best when combined with gradual dietary changes and increased physical activity, making your first month an ideal time to establish sustainable lifestyle modifications that support long-term success.
Making Your Decision: Accessing Both Options Through EverydayMeds
Both Wegovy and Mounjaro are available through EverydayMeds, allowing your prescriber to recommend the most suitable option based on your individual medical profile, lifestyle factors, and treatment preferences. Our clinical team works with you to ensure whichever treatment you start receives proper support through our ongoing care programme. Whether you choose Wegovy's established semaglutide approach or Mounjaro's dual-action tirzepatide mechanism, success depends on consistent administration, appropriate dose progression, and sustained lifestyle modifications. New customers can access Wegovy starter doses using code FIRST40, whilst returning patients benefit from code DOSE25 applied automatically at checkout. Our GPhC-registered pharmacy (#9012878) ensures both treatments meet the highest UK quality standards, with full MHRA compliance and proper cold-chain handling throughout the supply process. Remember that prescription-only medicines require ongoing prescriber supervision, and our team remains available to support your journey regardless of which treatment proves most effective for your individual circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
